GLSI - NASDAQ

Greenwich LifeSciences, Inc.

GLSI·NASDAQ

$24.29

-15%

HealthcareBiotechnology

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$356.53M

EPS-1.4300

P/E Ratio-16.99

Earnings Date06/02/2026

glsi

Total Liabilities

Last Annual Value

2.02M

3-Year CAGR

97%

5-Year CAGR

14%

10-Year CAGR

-13%

Adjust for Inflation

Greenwich LifeSciences, Inc. Competitors Analysis of Total Liabilities

GLSI · NASDAQ

Company	Total Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Greenwich LifeSciences, Inc. NASDAQ:GLSI	2.02M	89.9%	39.2%	N/A
TuHURA Biosciences, Inc. NASDAQ:HURA	6.42M	2.7%	-2.1%	17.0%
Seer, Inc. NASDAQ:SEER	36.78M	-2.2%	0.3%	N/A
Surrozen, Inc. NASDAQ:SRZN	286.49M	227.6%	59.8%	N/A
Acumen Pharmaceuticals, Inc. NASDAQ:ABOS	52.40M	6.7%	59.1%	N/A
Anixa Biosciences, Inc. NASDAQ:ANIX	2.13M	-0.3%	7.4%	-7.5%
C4 Therapeutics, Inc. NASDAQ:CCCC	102.49M	-7.7%	-2.6%	N/A
Cardiff Oncology, Inc. NASDAQ:CRDF	16.50M	11.5%	12.6%	-3.8%
Nuvectis Pharma, Inc. NASDAQ:NVCT	13.30M	23.9%	-5.5%	N/A
PepGen Inc. NASDAQ:PEPG	26.46M	-8.6%	20.2%	N/A
Opus Genetics, Inc. NASDAQ:IRD	34.90M	105.1%	55.4%	N/A

Greenwich LifeSciences, Inc. Fair Value Envelope

GLSI · NASDAQ

Our analysis suggests that GLSI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $24.29, this represents a potential HIDDEN relative to our calculated worth for Greenwich LifeSciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $24.29

Related Guides

Blog Categories

Continue your GLSI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.